2,052
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG29 and Pluronic® P85 unimers

, , , , &
Pages 1886-1897 | Received 26 Apr 2018, Accepted 05 Jun 2018, Published online: 07 Nov 2018

References

  • Alam MI, Beg S, Samad A, et al. (2010). Strategy for effective brain drug delivery. Eur J Pharm Sci 40:385–403.
  • Allen C, Yu Y, Eisenberg A, Maysinger D. (1999). Cellular internalization of PCL(20)-b-PEO(44) block copolymer micelles. Biochim Biophys Acta 1421:32–8.
  • Banks WA. (2012). Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier. Adv Drug Deliv Rev 64:629–39.
  • Bi Y, Liu L, Lu Y, et al. (2016). T7 Peptide-functionalized Peg-Plga micelles loaded with carmustine for targeting therapy of glioma. ACS Appl Mater Interfaces 8(41):27465–27473.
  • Brouwer MC, Tunkel AR, Van De Beek D. (2010). Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 23:467–92.
  • Chen B, He XY, Yi XQ, et al. (2015). Dual-peptide-functionalized albumin-based nanoparticles with ph-dependent self-assembly behavior for drug delivery. ACS Appl Mater Interfaces 7:15148–53.
  • Chen C, Duan Z, Yuan Y, et al. (2017). Peptide-22 and cyclic RGD functionalized liposomes for glioma targeting drug delivery overcoming BBB and BBTB. ACS Appl Mater Interfaces 9:5864–73.
  • Chen Y, Liu L. (2012). Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev 64:640–65.
  • Couchman W. (1996). The "in-between” times: video analysis of peer interactions. Br J Nurs 5:96–9.
  • Cui Y, Zhang M, Zeng F, et al. (2016). Dual-targeting magnetic Plga nanoparticles for codelivery of paclitaxel and curcumin for brain tumor therapy. ACS Appl Mater Interfaces 8:32159–69.
  • De Laat SW, Van Der Saag PT, Shinitzky M. (1977). Microviscosity modulation during the cell cycle of neuroblastoma cells. Proc Natl Acad Sci U S A 74:4458–61.
  • Dong N, Ma Q, Shan A, et al. (2012). Strand length-dependent antimicrobial activity and membrane-active mechanism of arginine- and valine-rich beta-hairpin-like antimicrobial peptides. Antimicrob Agents Chemother 56:2994–3003.
  • Egleton RD, Davis TP. (1997). Bioavailability and transport of peptides and peptide drugs into the brain. Peptides 18:1431–9.
  • Evers R, Kool M, Smith AJ, et al. (2000). Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br J Cancer 83:366–74.
  • Hong W, Chen D, Zhang X, et al. (2013). Reversing multidrug resistance by intracellular delivery of pluronic(R) P85 unimers. Biomaterials 34:9602–14.
  • Hong W, Zhao Y, Guo Y, et al. (2018). PEGylated self-assembled nano-bacitracin A: probing the antibacterial mechanism and real-time tracing of target delivery in vivo. ACS Appl Mater Interfaces 10:10688–705.
  • Hwang DW, Son S, Jang J, et al. (2011). A Brain-targeted rabies virus glycoprotein-disulfide linked Pei nanocarrier for delivery of neurogenic microrna. Biomaterials 32:4968–75.
  • Kim JS, Yoon TJ, Yu KN, et al. (2006). Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci 89:338–47.
  • Kim JY, Choi WI, Kim YH, Tae G. (2013). Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier. Biomaterials 34:1170–8.
  • Liu Y, Huang R, Han L, et al. (2009). Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials 30:4195–202.
  • Lo SL, Wang S. (2008). An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials 29:2408–14.
  • Ma QQ, Dong N, Shan AS, et al. (2012). Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units. Amino Acids 43:2527–36.
  • Miller DW, Batrakova EV, Waltner TO, et al. (1997). Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. Bioconjugate Chem 8:649–57.
  • Rapoport SI. (2001). Advances in osmotic opening of the blood-brain barrier to enhance Cns chemotherapy. Expert Opin Investig Drugs 10:1809–18.
  • Regev R, Assaraf YG, Eytan GD. (1999). Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. Eur J Biochem 259:18–24.
  • Smith MW, Gumbleton M. (2006). Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies. J Drug Target 14:191–214.
  • Tavano L, Muzzalupo R. (2016). Multi-functional vesicles for cancer therapy: the ultimate magic bullet. Colloids Surf B Biointerfaces 147:161–71.
  • Van De Beek D, De Gans J, Tunkel AR, Wijdicks EF. (2006). Community-acquired bacterial meningitis in adults. N Engl J Med 354:44–53.
  • Venne A, Li S, Mandeville R, et al. (1996). Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res 56:3626–9.
  • Wang Y, Li Y, Wang Q, et al. (2008). Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105/L101 mixed polymeric micelles. Yakugaku Zasshi 128:941–50.
  • Wang Y, Yu L, Han L, et al. (2007). Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. Int J Pharm 337:63–73.
  • Weisfelt M, De Gans J, Van Der Poll T, Van De Beek D. (2006). Pneumococcal Meningitis in adults: new approaches to management and prevention. Lancet Neurol 5:332–42.
  • Wilder-Smith A. (2007). Meningococcal vaccine in travelers. Curr Opin Infect Dis 20:454–60.
  • Xin H, Sha X, Jiang X, et al. (2012). The brain targeting mechanism of angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles. Biomaterials 33:1673–81.
  • Yamagata T, Kusuhara H, Morishita M, et al. (2007). Effect of excipients on breast cancer resistance protein substrate uptake activity. J Control Release 124:1–5.
  • Yin T, Xie W, Sun J, et al. (2016). Penetratin peptide-functionalized gold nanostars: enhanced BBB permeability and Nir photothermal treatment of Alzheimer's disease using ultralow irradiance. ACS Appl Mater Interfaces 8:19291–302.
  • Zhang W, Shi Y, Chen Y, et al. (2011). Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials 32:2894–906.
  • Zhou Y, Huang W, Liu J, et al. (2010). Self-assembly of hyperbranched polymers and its biomedical applications. Adv Mater Weinheim 22:4567–90.